Pharvaris NV (PHVS)
38.65
+0.91
(+2.41%)
USD |
NASDAQ |
Sep 10, 11:46
Pharvaris Price to Book Value : 7.890 for Sept. 10, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 09, 2026 | 7.704 |
| September 08, 2026 | 7.724 |
| September 04, 2026 | 7.196 |
| September 03, 2026 | 7.279 |
| September 02, 2026 | 7.179 |
| September 01, 2026 | 7.130 |
| August 31, 2026 | 7.065 |
| August 28, 2026 | 7.21 |
| August 27, 2026 | 7.553 |
| August 26, 2026 | 7.553 |
| August 25, 2026 | 7.600 |
| August 24, 2026 | 7.616 |
| August 21, 2026 | 7.404 |
| August 20, 2026 | 7.428 |
| August 19, 2026 | 7.404 |
| August 18, 2026 | 7.369 |
| August 17, 2026 | 7.21 |
| August 14, 2026 | 7.173 |
| August 13, 2026 | 6.949 |
| August 12, 2026 | 7.443 |
| August 11, 2026 | 7.026 |
| August 10, 2026 | 7.112 |
| August 07, 2026 | 7.126 |
| August 06, 2026 | 7.032 |
| August 05, 2026 | 6.822 |
| Date | Value |
|---|---|
| August 04, 2026 | 6.914 |
| August 03, 2026 | 6.583 |
| July 31, 2026 | 6.659 |
| July 30, 2026 | 6.916 |
| July 29, 2026 | 6.659 |
| July 28, 2026 | 6.868 |
| July 27, 2026 | 6.934 |
| July 24, 2026 | 6.975 |
| July 23, 2026 | 6.789 |
| July 22, 2026 | 7.014 |
| July 21, 2026 | 7.032 |
| July 20, 2026 | 6.849 |
| July 17, 2026 | 7.132 |
| July 16, 2026 | 6.871 |
| July 15, 2026 | 7.177 |
| July 14, 2026 | 7.026 |
| July 13, 2026 | 7.159 |
| July 10, 2026 | 7.159 |
| July 09, 2026 | 7.341 |
| July 08, 2026 | 7.334 |
| July 07, 2026 | 7.061 |
| July 06, 2026 | 6.781 |
| July 02, 2026 | 6.912 |
| July 01, 2026 | 6.930 |
| June 30, 2026 | 7.059 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Novartis AG | 6.093 |
| BioAge Labs, Inc. | 1.065 |
| AstraZeneca PLC | 10.45 |
| ANI Pharmaceuticals, Inc. | 2.714 |
| Corcept Therapeutics, Inc. | 17.69 |
Price to Book Value Related Metrics
| Price | 38.65 |
| Earnings Yield | -7.89% |
| Market Cap | 2.713B |